{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:49:19Z","timestamp":1782604159632,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-0892-7","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T02:26:47Z","timestamp":1461896807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Manuela","family":"Robella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"issue":"1","key":"892_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28(1):63\u20138.","journal-title":"J Clin Oncol"},{"issue":"10","key":"892_CR2","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1093\/annonc\/mds203","volume":"23","author":"LC Hanker","year":"2012","unstructured":"Hanker LC, Loibl S, Burchardi N, AGO and GINECO study group, et al. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane\/platinum-based therapy. Ann Oncol. 2012;23(10):2605\u201312.","journal-title":"Ann Oncol"},{"issue":"4","key":"892_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ctrv.2007.01.004","volume":"33","author":"F Rivera","year":"2007","unstructured":"Rivera F, Vega-Villegas ME, L\u00f3pez-Brea MF. Chemotherapy of advanced gastric cancer. Cancer Treat Rev. 2007;33(4):315\u201324.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"892_CR4","first-page":"59","volume":"52","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Morris DL. Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management. Can J Surg. 2009;52(1):59\u201364.","journal-title":"Can J Surg"},{"key":"892_CR5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4613-1247-5_6","volume":"82","author":"PH Sugarbaker","year":"1996","unstructured":"Sugarbaker PH. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Cancer Treat Res. 1996;82:79\u2013100.","journal-title":"Cancer Treat Res"},{"issue":"11","key":"892_CR6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/ans.12306","volume":"83","author":"L Ung","year":"2013","unstructured":"Ung L, Chua TC, Morris DL. Cure for peritoneal metastases? An evidence-based review. ANZ J Surg. 2013;83(11):821\u20136.","journal-title":"ANZ J Surg"},{"issue":"6","key":"892_CR7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jso.22017","volume":"104","author":"RS Gill","year":"2011","unstructured":"Gill RS, Al-Adra DP, Nagendran J, et al. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol. 2011;104(6):692\u20138.","journal-title":"J Surg Oncol"},{"issue":"2","key":"892_CR8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, M\u00fcrdter T, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21(2):553\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"23\u201324","key":"892_CR9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10354-014-0312-y","volume":"164","author":"CB Tempfer","year":"2014","unstructured":"Tempfer CB, Solass W, Reymond MA. Pressurized intraperitoneal chemotherapy (PIPAC) in women with gynecologic malignancies: a review. Wien Med Wochenschr. 2014;164(23\u201324):519\u201328.","journal-title":"Wien Med Wochenschr"},{"issue":"2","key":"892_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","volume":"137","author":"CB Tempfer","year":"2015","unstructured":"Tempfer CB, Winnekendonk G, Solass W, et al. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol. 2015;137(2):223\u20138.","journal-title":"Gynecol Oncol"},{"key":"892_CR11","doi-asserted-by":"crossref","unstructured":"Nadiradze G, Giger-Pabst U, Zieren J, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis. J Gastrointest Surg. 2015;28 [Epub ahead of print].","DOI":"10.1007\/s11605-015-2995-9"},{"key":"892_CR12","doi-asserted-by":"crossref","unstructured":"Demtr\u00f6der C, Solass W, Zieren J, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis. 2015;24 [Epub ahead of print].","DOI":"10.1111\/codi.13130"},{"key":"892_CR13","doi-asserted-by":"crossref","unstructured":"Oyais A, Solass W, Zieren J, Reymond MA, Giger-Pabst U et al. Occupational health aspects of pressurised intraperitoneal aerosol chemotherapy (PIPAC): confirmation of harmlessness. Zentralbl Chir. 2014 [Epub ahead of print].","DOI":"10.1245\/s10434-013-3039-x"},{"issue":"11","key":"892_CR14","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","volume":"20","author":"W Solass","year":"2013","unstructured":"Solass W, Giger-Pabst U, Zieren J, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol. 2013;20(11):3504\u201311.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"892_CR15","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","volume":"20","author":"A Blanco","year":"2013","unstructured":"Blanco A, Giger-Pabst U, Solass W, Zieren J, Reymond MA. Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol. 2013;20(7):2311\u20136.","journal-title":"Ann Surg Oncol"},{"key":"892_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"issue":"1","key":"892_CR17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","volume":"244","author":"P Esquis","year":"2006","unstructured":"Esquis P, Consolo D, Magnin G, et al. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244(1):106\u201312.","journal-title":"Ann Surg"},{"issue":"5","key":"892_CR18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00001813-199607000-00016","volume":"7","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Stuart OA, Chang D, Sugarbaker PH. Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs. 1996;7(5):596\u2013603.","journal-title":"Anticancer Drugs"},{"issue":"4","key":"892_CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000356758","volume":"59","author":"C Battelli","year":"2013","unstructured":"Battelli C, Campo M, Buss MK, Awtrey CS, Konstantinopoulos PA. Safety and outcome of patients treated with a modified outpatient intraperitoneal regimen for epithelial ovarian, primary peritoneal or fallopian tube cancer. Chemotherapy. 2013;59(4):251\u20139.","journal-title":"Chemotherapy"},{"issue":"1","key":"892_CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2004.12.005","volume":"97","author":"K Fujiwara","year":"2005","unstructured":"Fujiwara K, Markman M, Morgan M, Coleman RL. Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer. Gynecol Oncol. 2005;97(1):10\u20135.","journal-title":"Gynecol Oncol"},{"key":"892_CR21","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"F Verwaal","year":"2003","unstructured":"Verwaal F, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol"},{"issue":"16","key":"892_CR22","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22(16):3284\u201392.","journal-title":"J Clin Oncol"},{"issue":"9","key":"892_CR23","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15(9):2426\u201332.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"892_CR24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27(5):681\u20135.","journal-title":"J Clin Oncol"},{"issue":"1","key":"892_CR25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Gynecologic Oncology Group, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354(1):34\u201343.","journal-title":"N Engl J Med"},{"issue":"5","key":"892_CR26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1525-1438.2007.01163.x","volume":"18","author":"A Gadducci","year":"2008","unstructured":"Gadducci A, Conte PF. Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature. Int J Gynecol Cancer. 2008;18(5):943\u201353.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"892_CR27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2005.12.006","volume":"100","author":"EL Trimble","year":"2006","unstructured":"Trimble EL, Christian MC. Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma. Gynecol Oncol. 2006;100(1):3\u20134.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"892_CR28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/IGC.0b013e3181c50cde","volume":"20","author":"CW Helm","year":"2010","unstructured":"Helm CW, Richard SD, Pan J, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer. 2010;20(1):61\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"892_CR29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1586\/era.12.72","volume":"12","author":"E Bree De","year":"2012","unstructured":"De Bree E, Helm CW. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: rationale and clinical data. Expert Rev Anticancer Ther. 2012;12(7):895\u2013911.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"892_CR30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","volume":"122","author":"M Deraco","year":"2011","unstructured":"Deraco M, Kusamura S, Virz\u00ec S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. Gynecol Oncol. 2011;122(2):215\u201320.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"892_CR31","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1586\/era.11.147","volume":"11","author":"MA Str\u00f6hlein","year":"2011","unstructured":"Str\u00f6hlein MA, Bulian DR, Heiss MM. Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer. Expert Rev Anticancer Ther. 2011;11(10):1505\u20138.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"892_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1245\/s10434-009-0756-2","volume":"17","author":"D Baratti","year":"2010","unstructured":"Baratti D, Kusamura S, Cabras AD, et al. Lymph node metastases in diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2010;17(1):45\u201353.","journal-title":"Ann Surg Oncol"},{"issue":"36","key":"892_CR33","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27(36):6237\u201342.","journal-title":"J Clin Oncol"},{"issue":"3","key":"892_CR34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jso.10255","volume":"83","author":"M Deraco","year":"2003","unstructured":"Deraco M, Casali P, Inglese MG, et al. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol. 2003;83(3):147\u201353.","journal-title":"J Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-0892-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T03:50:41Z","timestamp":1567828241000},"score":1,"resource":{"primary":{"URL":"http:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-016-0892-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["892"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-0892-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]},"article-number":"128"}}